SPDR S&P Pharmaceuticals ETF (XPH)
NYSEARCA: XPH · Real-Time Price · USD
40.16
+0.30 (0.75%)
Apr 25, 2025, 4:00 PM EDT - Market closed
XPH Holdings List
As of Apr 24, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | CORT | Corcept Therapeutics Incorporated | 5.34% |
2 | LLY | Eli Lilly and Company | 4.28% |
3 | TARS | Tarsus Pharmaceuticals, Inc. | 4.12% |
4 | RPRX | Royalty Pharma plc | 3.99% |
5 | JNJ | Johnson & Johnson | 3.89% |
6 | ZTS | Zoetis Inc. | 3.85% |
7 | ELAN | Elanco Animal Health Incorporated | 3.72% |
8 | PRGO | Perrigo Company plc | 3.70% |
9 | PBH | Prestige Consumer Healthcare Inc. | 3.70% |
10 | PFE | Pfizer Inc. | 3.62% |
11 | AXSM | Axsome Therapeutics, Inc. | 3.61% |
12 | VTRS | Viatris Inc. | 3.55% |
13 | MRK | Merck & Co., Inc. | 3.50% |
14 | BMY | Bristol-Myers Squibb Company | 3.33% |
15 | JAZZ | Jazz Pharmaceuticals plc | 3.32% |
16 | OGN | Organon & Co. | 3.30% |
17 | PCRX | Pacira BioSciences, Inc. | 3.29% |
18 | ARVN | Arvinas, Inc. | 2.88% |
19 | HRMY | Harmony Biosciences Holdings, Inc. | 2.79% |
20 | AMPH | Amphastar Pharmaceuticals, Inc. | 2.45% |
21 | EWTX | Edgewise Therapeutics, Inc. | 2.36% |
22 | ANIP | ANI Pharmaceuticals, Inc. | 2.20% |
23 | SUPN | Supernus Pharmaceuticals, Inc. | 2.14% |
24 | LGND | Ligand Pharmaceuticals Incorporated | 1.89% |
25 | HROW | Harrow, Inc. | 1.88% |
26 | LQDA | Liquidia Corporation | 1.73% |
27 | COLL | Collegium Pharmaceutical, Inc. | 1.71% |
28 | INVA | Innoviva, Inc. | 1.63% |
29 | AMRX | Amneal Pharmaceuticals, Inc. | 1.30% |
30 | WVE | Wave Life Sciences Ltd. | 1.12% |
31 | CRMD | CorMedix Inc. | 1.11% |
32 | MNMD | Mind Medicine (MindMed) Inc. | 1.11% |
33 | OCUL | Ocular Therapeutix, Inc. | 1.10% |
34 | EOLS | Evolus, Inc. | 1.07% |
35 | NUVB | Nuvation Bio Inc. | 0.85% |
36 | XERS | Xeris Biopharma Holdings, Inc. | 0.81% |
37 | OMER | Omeros Corporation | 0.80% |
38 | EYPT | EyePoint Pharmaceuticals, Inc. | 0.78% |
39 | ELVN | Enliven Therapeutics, Inc. | 0.62% |
40 | PAHC | Phibro Animal Health Corporation | 0.49% |
41 | ZVRA | Zevra Therapeutics, Inc. | 0.47% |
42 | ESPR | Esperion Therapeutics, Inc. | 0.45% |
43 | - | SSI US GOV MONEY MARKET CLASS | 0.12% |
As of Apr 24, 2025